Hnixcare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2020)
- Profit -414.38%
(FY 2020)
- Ebitda -970.00%
(FY 2020)
- Net Worth -96.63%
(FY 2020)
- Total Assets -88.34%
(FY 2020)
About Hnixcare Pharmaceuticals
The Corporate was formerly known as Dr Chand's Pharmaceuticals Private Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Neha Suman and Henimen Suman serve as directors at the Company.
- CIN/LLPIN
U74999BR2018PTC037064
- Company No.
037064
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2018
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Saharsa, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hnixcare Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Suman  | Director | 07-Feb-2018 | Current |
| Henimen Suman | Director | 07-Feb-2018 | Current |
Financial Performance of Hnixcare Pharmaceuticals.
Hnixcare Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 414.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 96.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hnixcare Pharmaceuticals?
Unlock access to Hnixcare Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Zynokem Laboratories Private LimitedActive 4 years 11 monthsNeha Suman and Henimen Suman are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hnixcare Pharmaceuticals?
Unlock and access historical data on people associated with Hnixcare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hnixcare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hnixcare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
